Friday, April 29, 2022 12:21 AM
ALPHARETTA, Ga.—Visioneering Technologies, Inc.
(ASX: VTI), the Alpharetta, Ga.-based medical device company and producer of the NaturalVue Enhanced Multifocal 1 Day Contact Lenses, has announced several changes to the commercial organization within the company.
Wednesday, April 27, 2022 12:18 AM
WAUWATOSA, Wisc.—John Fried, a longtime optical industry executive, passed away peacefully in his home here on April 8 due to complications stemming from amyotrophic lateral sclerosis.
Monday, April 18, 2022 12:24 AM
CHARENTON-LE-PONT, France, and SCHIPHOL, The Netherlands—With its acquisition of GrandVision completed, EssilorLuxottica
(Euronext: EL) announced Friday that it has made changes to the GrandVision
management team. Stephan Borchert and Willem Eelman have decided to step down from their roles as chief executive officer and chief financial officer of GrandVision, respectively, effective April 22.
Monday, April 18, 2022 12:21 AM
SAN DIEGO, Calif.—Shamir Insight
announced several changes in its executive leadership, effective April 1. Pierson Ball, the company’s director of business and strategic development has been appointed vice president of sales.
Friday, March 18, 2022 12:18 AM
NEW YORK—Bryan Wolynski, OD, FAAO, has been named chief technology officer at Lighthouse Guild
, the leading organization dedicated to providing services that inspire people who are visually impaired to attain their goals. Dr. Wolynski will oversee all technology resources for the organization, including the recently opened Lighthouse Guild Technology Center.
Wednesday, March 16, 2022 12:27 AM
SAN RAMON, Calif.—CooperVision Specialty EyeCare
has appointed Tony Sommer Jr. as general manager, Americas. Sommer will lead the organization’s continued growth and projected category expansion across the U.S., Canada and Latin America, beginning this April, according to a CooperVision announcement this week. Sommer—who has two decades of industry-related experience—most recently served as senior vice president of sales and marketing for Visioneering Technologies Inc., where he led strategic planning and commercial operations for the company’s contact lens portfolio.
Tuesday, March 1, 2022 12:15 AM
BOULDER, Colo.—Sanitas Advisors'
and its founder, Bart Foster, will be hosting a BusinessOutside
Connection Hike in the mid-afternoon of March 31 in New York's Central Park. Sanitas is inviting industry participants who will be in the city for Vision Expo East
to take part in a unique outdoor event to create meaningful business connections. The hike will take place from 12:30 p.m. to 2:30 p.m. and be approximately four miles. Stated Foster, "BusinessOutside is a movement to get people Outside, literally and figuratively. Outside of their comfort zone, outside of outdated corporate norms, and outside in nature. BusinessOutside is based on more than individual likes and lifestyles; it is based on research and data. It’s a science-inspired philosophy."
Thursday, February 24, 2022 3:12 PM
In a recent Women In Optometry Pop-up Poll
, respondents said that finding staff was a challenge. This time, WO
asked respondents to share their recruiting resources and benefits to hire or retain current staff. Fully 81 percent of respondents said that they increased pay and benefits packages since the start of the coronavirus pandemic. It’s a huge difference compared to the 13 percent of respondents who said they didn’t make or see salary changes and the six percent of respondents who said they had to scale back staff funding.
Higher salaries are also an important recruiting tool, with 80 percent saying that they had to boost pay or benefits to recruit staff. Another popular method was adding flexible time, such as a designated or extended lunch break or shift changes.
Retirement plan funding and greater insurance benefits for health, dental and vision were also additional incentives offered to staff. Many businesses are struggling to onboard new employees, and it’s also impacting the optometry side, respondents said.
Friday, January 21, 2022 12:27 AM
LAVAL, QC—Bausch Health Companies
has announced that Dr. Yehia Hashad will join Bausch + Lomb Corp.
as executive vice president of research & development (R&D) and chief medical officer (CMO), effective Jan. 31.
Friday, January 21, 2022 12:21 AM
COLUMBIA, Md.—The Foundation Fighting Blindness
announced the promotion of Jason Menzo to president and chief operating officer, effective immediately.
Tuesday, January 18, 2022 12:18 AM
CORALVILLE, Iowa—Digital Diagnostics
recently announced the designation of co-founder has been given to the company’s CEO and president/COO, John Bertrand and Seth Rainford, respectively after a board vote. The new designations follow the company name change from IDx to Digital Diagnostics. These C-suite updates recognize the growth plans and innovation as the company seeks to advance the use of artificial intelligence (AI) across additional clinical applications.
Wednesday, January 12, 2022 12:24 AM
GOLDEN, Colo.—Optometry Giving Sight
(OGS) announces Sharyn Gallatin as the new director of development, North America, and the retirement of Eric Anderson, director of donor engagement, North America.
Wednesday, January 12, 2022 12:15 AM
SANTA ROSE, Calif.—Twenty-year senior corporate executive for SOLA Optical USA, Inc. and SOLA International, Inc., and long-time, highly-regarded optical industry advisor, contributing editor and professional speaker, Hedley Lawson, has announced his retirement. Lawson began his optical industry career in 1980 with SOLA Optical USA as director of human resources. He was a key member of the executive leadership team, serving in various senior management roles. He was instrumental in the integration of numerous acquisitions including Syntex Ophthalmics, Coburn and American Optical.
Monday, January 10, 2022 12:15 AM
MORRISTOWN, N.J.—Melinta Therapeutics, LLC
, a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announced that president and CEO Christine Ann Miller has been elected to the board of directors of Iveric Bio, Inc.
, effective immediately. Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs. The company is committed to having a positive impact on patients’ lives by delivering high-quality, safe and effective treatments designed to address debilitating retina diseases including all stages of age-related macular degeneration, according to a statement from Melinta Therapeutics.
Monday, December 20, 2021 12:21 AM
DURHAM, N.C.—Aerie Pharmaceuticals
(NASDAQ:AERI), an ophthalmic pharmaceutical company, announced that Raj Kannan will join the company as chief executive officer and a director, effective Dec. 20, 2021. Benjamin F. McGraw, III, PharmD, executive chairman of Aerie’s board of directors, said that Kannan “brings a track record of building effective organizations and teams, launching and growing products in the U.S. and globally, building commercial operations, providing strategic direction to pipeline development and successfully guiding companies through important inflections in their growth trajectories.